Is This Biotech Stock a Buy Near Its 52-Week High?
It's been a volatile year for the company, but don't let that scare you away.
Read the full articleYou might also wanna read

Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?
Investors favored companies benefiting from biotech deals, rising power demand from AI data centers, and cost-cutting efforts to improve pro

STAT+: Halfway into the year, biotech is booming
The biotech stock rally that began in April 2025 has not stopped, and if anything, has accelerated.

Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise
Retail traders are watching to see whether ImmunityBio could announce preliminary Q2 revenue, with some speculating that demand for Anktiva
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group he says has quie

This medtech stock is trading at a discount to peers. BTIG says it's a buy
Medtronic's shares are cheap relative to those of its competitors, making now a good time to add the stock to one's portfolio, per BTIG.
With Micron’s stock well off its peak, investors want proof that the AI boom can last
Investors in memory stocks are looking for signs that elevated pricing can be sustained for years without demand suffering.

Comments
Sign in to join the conversation.
No comments yet. Be the first.